Skip to main content

Nasdaq News

Why Canopy Growth Stock Jumped Today

6 years 2 months ago
What happened Shares of Canopy Growth (NYSE: CGC) climbed 7.8% on Monday, following the release of the marijuana producer's better-than-expected fiscal 2021 first-quarter results. 

The Weird Reason That Beyond Meat Slumped on Monday

6 years 2 months ago
What happened A stock usually pops in value when an influential analyst ups a price target, particularly when said price target is nearly tripled. But on Monday, Beyond Meat (NASDAQ: BYND) fell by over 3% despite getting much more juice from Goldman Sachs.

Australia shares set to open flat, NZ rises

6 years 2 months ago
Australian shares were poised to open little changed on Tuesday as investors await news on progress on a U.S. fiscal support bill and keep a close eye on coronavirus data after signs that a second wave of local infections may be peaking.

TSX Ends Modestly Higher

6 years 2 months ago
(RTTNews) - The Canadian stock market suffered a setback after a positive start Monday morning, but recovered swiftly and stayed firm thereafter to eventually close the session modestly higher.

HC2 Holdings (HCHC) Q2 Earnings Top Estimates

6 years 2 months ago
HC2 Holdings (HCHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of a loss of $0.39 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.

Uniti Group (UNIT) Misses Q2 FFO Estimates

6 years 2 months ago
Uniti Group (UNIT) came out with quarterly funds from operations (FFO) of $0.44 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to FFO of $0.55 per share a year ago. These figures are adjusted for non-recurring items.

Mesa Air Group Q3 Profit Up

6 years 2 months ago
(RTTNews) - Mesa Air Group, Inc. (MESA) Monday reported third-quarter net income of $3.4 million or $0.10 per share, up from $3.0 million or $0.09 per share last year.

Why Axsome Therapeutics Stock Rose Today

6 years 2 months ago
What happened? Shares of Axsome Therapeutics (NASDAQ: AXSM) -- a clinical-stage biotech -- rose sharply on Monday and closed the day's trading session up by 4.8%, following the company's release of its second-quarter financial results. The most important part of Axsome's quarter
Checked
17 minutes 10 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed